strategic marketing

profilePreethi D
SivaTermPaperGradingRubrics2.docx

Term Paper

MG 625 Strategy and Decision Analysis in Healthcare Grading Rubrics

STAGE I: Title and Abstract>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> 5%

Title: State your research problem in the form of question addressing the cost effectiveness with interventions compared.

Abstract: State a structured summary in terms of objectives, data sources, researching findings, methods and conclusion, that is, have resolves the problem

STAGE II: Introduction >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>10%

In the introduction, which is less formal is to develop a story and should the followings:

a) Background information:

-what is the nature of the disease and its impact under study- the impact refers to the epidemiological ( incidence and its spread ) and economic impact of the disease on society .

b) State the research questions: a broader context as to why the study is important

--the need for a cost-effectiveness analysis( evaluates the intervention used to treat and or prevent this disease because of the uncertain outcomes; that is the vaccine efficacy outweighs other intervention ( supportive care).

-the analysis will help to resolve the problem

c) Data sources: use of secondary data

State the purpose or the central theme of your paper. Purpose: To evaluate the cost effectiveness of a medical intervention compared to another to another comparator, using secondary data ( already published) to measure outcomes in life years gained and the cost of life years.

d) The purpose is to two-fold:

i) Descriptive: that is to state a summary of the costs and life years gained by the medical intervention.

ii) One-way analysis in making prediction: how will the health outcomes change if the costs were to change incrementally

STAGE II: Body of the paper ……………………………………………...……... (70%)

In this section, discuss the methodological/theoretical framework and empirical findings/one way sensitivity analysis of your medical intervention.

Descriptive and One-Way Prediction

a) Methods section is descriptive of the data gathered and includes the followings:

-Demographic profile of the cohort group in the US Health System

-Cost Perspectives of the study (societal, governmental, patient, payer)

-Model the event pathway( decision tree diagram)

-Time horizon over which data on costs and health outcomes are gathered

-State how the Health outcomes in QALYs and QALE

-Comparators: describe the interventions(strategies) being compared and why?

b) One-way sensitivity analysis (chapter 9) refers to how the outcomes will change if the costs were to change.

Once you have identified the costs per life year gain and health outcomes, perform a one sensitivity test by changing the costs and determine how much the outcomes will change in QALYs. Use secondary data and existing literature to answer my research question.

Table Showing a summary of the costs used in a Cost-Effective Model

Intervention Costs

Cost per period (day)

Reference

Linezolid 600 mg twice per day

$14

Red Book( 2009)

Vancomycin 1000 mg twice per day

250

Red Book (2009)

Microbiological Culture

25

HCUP ( 2009)

Monitoring Costs

10

HCUP ( 2009)

Use the above costs in your decision tree analysis for illustration

c. Results section provides a report of what you have discovered and explanations, such as the Tables below.>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> 10%

Cost- Effectiveness Table

Intervention

Total Cost

Total Effectiveness

Incremental Cost

Incremental Effectiveness

Benefits/gains

Incremental Cost Effectiveness

Usual Care(1)

Cost of Usual Care

Total QALYs in usual care cohort

Intervention 2

Cost of intervention

-savings from intervention

Total QALYs in intervention cohort

A2 -A1

= C2

B2-B1

=D2

C2/D2

Intervention3

Cost of intervention

-costs from intervention

Total QALYs in intervention cohort

A3-A2

=C3

B3-B2

= D3

C3/D3

-Rank interventions from least effective ( top)

-Incremental cost: subtract the usual cost data from the intervention

-Usual Care: lowest number of QALYs followed by Intervention 2

-Intervention 2: ICER compares Intervention 2 to the Usual Care

Table Showing a numerical Example of a Cost- Effectiveness

Intervention

Total Cost

Total Effectiveness

Incremental Cost

Incremental Effectiveness

Benefits/gains

Incremental Cost Effectiveness

Usual Care(1)

$100

.5QALY

Intervention 2

$250

.7QALY

250-100 = 150

.7-.5 = .2

150/.2 = $750

Intervention3

$200

.78QALY

200-250 = -50

.78-.7 = .08

Dominated

Interpretation: Intervention 2 provides $750 per QALY

d. Discussion:

-Try to connect your results with your research questions

-What does your results show?

-What have other studies report?

STAGE III: Summary, Conclusion and References…………………………. (10%)

a. Summary: in about one paragraph or so, summarize the key findings of your industry.

b. Conclusion: Have your results support your research questions?

c. Recommendations for future study

-more data needed for costs/probability

d. References: In-text Citations (quote least 2 sources); paraphrase and appropriate referencing. Reference page: two or more sources-hanging indentation

STAGE IV: Format of your Term Paper………………………………………. (5%)

a. APA Style

-indentations

-running head

-page numbering

-appropriate subheadings

-Times Font Numeral

-Errors Free

-double line

b. About 6-7 pages in length:

TOTAL: ---------------------------------------------------------------------------------100%